Manufactured meals: The challenges of ultraprocessed foods.

IF 15.8 1区医学 Q1 Medicine

PLoS Medicine Pub Date : 2024-10-15 eCollection Date: 2024-10-01 DOI:10.1371/journal.pmed.1004477

Alexandra Tosun

引用次数: 0

Abstract

In this Editorial on behalf of the PLOS Medicine Editors, Alexandra Tosun discusses how ultra-processed food has found itself at the center of a growing storm of criticism, the complexities of the ongoing nutrition debate and why stakeholders must be held to higher standards.

查看原文本刊更多论文

人造膳食：超加工食品的挑战。

在这篇代表《PLOS 医学》编辑的社论中，亚历山德拉-托森（Alexandra Tosun）讨论了超加工食品如何成为越来越多批评风暴的中心、正在进行的营养辩论的复杂性以及为什么必须对利益相关者提出更高的标准。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

PLoS Medicine MEDICINE, GENERAL & INTERNAL-

CiteScore

17.60

自引率

0.60%

发文量

227

审稿时长

4-8 weeks

期刊介绍： PLOS Medicine is a prominent platform for discussing and researching global health challenges. The journal covers a wide range of topics, including biomedical, environmental, social, and political factors affecting health. It prioritizes articles that contribute to clinical practice, health policy, or a better understanding of pathophysiology, ultimately aiming to improve health outcomes across different settings. The journal is unwavering in its commitment to uphold the highest ethical standards in medical publishing. This includes actively managing and disclosing any conflicts of interest related to reporting, reviewing, and publishing. PLOS Medicine promotes transparency in the entire review and publication process. The journal also encourages data sharing and encourages the reuse of published work. Additionally, authors retain copyright for their work, and the publication is made accessible through Open Access with no restrictions on availability and dissemination. PLOS Medicine takes measures to avoid conflicts of interest associated with advertising drugs and medical devices or engaging in the exclusive sale of reprints.